About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.


News
ESDR mourns Prof Malcolm greaves
We are sad to announce that Professor Malcolm Greaves passed away on Sunday 10 January.Prof...
Journal of Investigative Dermatology – Editor Search
The Society for Investigative Dermatology (SID) in collaboration with the European Society...
Anniversary celebrations in 2021
Do you have any photos from ESDR meetings you have attended in the past that you are willing to...
ESDR 2021 update
With less than a year to go to the rescheduled 50th Anniversary meeting in Amsterdam, ESDR is...
New Job opportunities page on the ESDR website
Access our new Job opportunities page, search for your next career opportunity or send us you...
JID Innovations: Skin Science from Molecules to Population Health
Elsevier is pleased to announce the January 2021 launch of JID Innovations: Skin Science from...
ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.


JID Latest
- A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis
- Dermal adipose tissue secretes HGF to promote human hair growth and pigmentation
- DNA Damage and the Aging Epigenome
- Short-term Western diet intake promotes IL-23-mediated skin and joint inflammation accompanied by changes to the gut microbiota in mice
- Filaggrin variation differs for European-Americans and African-Americans